@joel_c_miller It depends on whether the analysis is designed to answer questions about what we know or what we should do. What’s the point of the study? Who is the audience?
Please look at Figure 4:
https://t.co/7QW8mMa6p6
Drug resistance (mainly chloroquine, but SP too) were rising during the 1990s. Some people wanted to blame rising cases on temperature. Drug policy changed, temperature kept going up, but cases stopped rising. Do the math.
This article is infuriating. In particular, the discussion of the Kericho data and analysis of it. The salient point, ignored by the commentary, is that if you follow the data set a few years longer, temperature kept rising, but malaria cases didn't.
https://t.co/2RWHJaiubq
I would like to announce that I have been studying Darmok in order to speak only through allegory.
I am freeing myself from the need to speak plainly ever again.
Picard and Dathon at El-Adrel.
New data from @WHO and @UNICEF show promising signs of recovery in global vaccination rates. But this progress hasn’t happened equally around the world, with many low-income countries faring the worst. https://t.co/hnOmkOe0Bk
@Fredros_Inc Local knowledge and the local populations are the most underused resource at present, IMO.
It’s time to invest more in education and engaging politicians in the fight.
@Carlos_Chaccour@alt_dave_smith@JuanCGabaldon You think a cluster of cases in a high resource setting is evidence that eradicating vivax is impossible.
I think that’s not attentive to history.
@Carlos_Chaccour@alt_dave_smith@JuanCGabaldon Make an argument that these cases threaten progress in some real way, and I might be convinced.
Otherwise, I think that they must be seen, as I’ve said, in their context as quite ordinary.
Since vivax keeps failing to reestablish, over decades, here & elsewhere…